GlassScriptPhysician profile
Kathleen A Wohldmann
NPI 1619484268
$4,101.83
in general payments reported to CMS, 2019-2025
26 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $115 · 2023: $2,487 · 2024: $1,183 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,035 · Travel and Lodging: $754 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,034.50 |
| Travel and Lodging | $753.99 |
| Education | $197.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,283.64 | 2022-2024 | Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $428.47 | 2022-2025 | Farxiga, Andexxa, Brilinta |
| Novartis Pharmaceuticals Corporation | $325.75 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $290.60 | 2022-2024 | Verquvo, Belsomra, Steglatro |
| Pfizer INC. | $251.71 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $196.19 | 2024-2025 | Assure Wcd |
| Amgen INC. | $145.00 | 2023-2024 | Repatha |
| Novo Nordisk INC | $132.37 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Actelion Pharmaceuticals US, INC. | $115.55 | 2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.60 | 2023-2024 | Lifevest |
| Esperion Therapeutics, INC. | $107.77 | 2023-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.24 | 2023-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $98.12 | 2023-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $83.15 | 2023-2024 | |
| Kiniksa Pharmaceuticals, LTD. | $78.51 | 2022-2023 | Arcalyst |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $72.51 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kiniksa Pharmaceuticals International, Plc | $65.25 | 2024 | Arcalyst |
| Abbvie INC. | $57.98 | 2024-2025 | |
| Abiomed | $38.37 | 2024 | Impella |
| Impulse Dynamics (USA) INC. | $27.22 | 2024 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $18.97 | 2024 | |
| Medtronic, INC. | $17.23 | 2023 | Linq II |
| Scpharmaceuticals INC. | $17.06 | 2023 | |
| Exact Sciences Corporation | $15.75 | 2024 | Cologuard Collection Kit |
| Heartflow, INC. | $14.70 | 2025 | |
| Cvrx, INC. | $10.12 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Wohldmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.